These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 4056037

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis.
    Nakagawa Y, Parks JH, Kézdy FJ, Coe FL.
    Trans Assoc Am Physicians; 1985; 98():281-9. PubMed ID: 3842199
    [No Abstract] [Full Text] [Related]

  • 5. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG, Bek-Jensen H, Fornander AM, Nilsson MA.
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Determination of protein-bound urinary gamma-carboxyglutamic acid in calcium nephrolithiasis.
    Colette C, Benmbarek A, Boniface H, Astre C, Pares-Herbute N, Monnier L, Guitter J.
    Clin Chim Acta; 1991 Dec 31; 204(1-3):43-50. PubMed ID: 1819473
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Urinary calcium oxalate crystal growth inhibitors.
    Worcester EM.
    J Am Soc Nephrol; 1994 Nov 31; 5(5 Suppl 1):S46-53. PubMed ID: 7873744
    [Abstract] [Full Text] [Related]

  • 10. Influence of gender and age on calcium oxalate crystal growth inhibition by urine from relatives of stone forming patients.
    Bergsland KJ, Kinder JM, Asplin JR, Coe BJ, Coe FL.
    J Urol; 2002 Jun 31; 167(6):2372-6. PubMed ID: 11992040
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
    Cerini C, Geider S, Dussol B, Hennequin C, Daudon M, Veesler S, Nitsche S, Boistelle R, Berthézène P, Dupuy P, Vazi A, Berland Y, Dagorn JC, Verdier JM.
    Kidney Int; 1999 May 31; 55(5):1776-86. PubMed ID: 10231440
    [Abstract] [Full Text] [Related]

  • 13. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
    Guerra A, Allegri F, Meschi T, Adorni G, Prati B, Nouvenne A, Novarini A, Maggiore U, Fiaccadori E, Borghi L.
    Clin Chem Lab Med; 2005 May 31; 43(6):585-9. PubMed ID: 16006253
    [Abstract] [Full Text] [Related]

  • 14. Reduced inhibitory activity of uronic-acid-rich protein in urine of stone formers.
    Atmani F, Lacour B, Jungers P, Drüeke T, Daudon M.
    Urol Res; 1994 May 31; 22(4):257-60. PubMed ID: 7871640
    [Abstract] [Full Text] [Related]

  • 15. Low specific gravity urine with crystalluria as discriminant index for nephrolithiasis.
    Sriboonlue P, Prasongwattana V, Sriboonlue M, Chata K, Tungsanga K, Sitprija V.
    J Med Assoc Thai; 1990 Nov 31; 73(11):634-40. PubMed ID: 2283493
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Concentration of a potent calcium oxalate monohydrate crystal growth inhibitor in the urine of normal persons and kidney stone patients by ELISA-based assay system employing monoclonal antibodies.
    Moghadam MF, Tandon C, Aggarwal S, Singla SK, Singh SK, Sharma SK, Varshney GC, Jethi RK.
    J Cell Biochem; 2003 Dec 15; 90(6):1261-75. PubMed ID: 14635198
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus.
    Liu J, Chen J, Wang T, Wang S, Ye Z.
    J Urol; 2005 Jan 15; 173(1):113-6. PubMed ID: 15592049
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.